Tranylcypromine
Tranylcypromine is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Tranylcypromine. Available dosage form: tablet.
Drug Details
- Generic Name
- Tranylcypromine
- Brand Names
- Tranylcypromine
- Application Number
- ANDA206856
- Sponsor
- Novitium Pharma LLC
- NDC Codes
- 1
- Dosage Forms
- TABLET
- Routes
- ORAL
- Active Ingredients
- TRANYLCYPROMINE SULFATE
Indications and Usage
1 INDICATIONS AND USAGE PARNATE is indicated for the treatment of major depressive disorder (MDD) in adult patients who have not responded adequately to other antidepressants. PARNATE is not indicated for the initial treatment of MDD due to the potential for serious adverse reactions and drug interactions, and the need for dietary restrictions [ see Contraindications (4) , Warnings and Precautions (5) , and Drug Interactions (7) ] . PARNATE is a monoamine oxidase inhibitor (MAOI) indicated for the treatment of major depressive disorder (MDD) in adult patients who have not responded adequately to other antidepressants (1) PARNATE is not indicated for the initial treatment of MDD due to the potential for serious adverse reactions and drug interactions, and the need for dietary restrictions ( 1 , 4 , 5 , 7 )